UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Journal of hematology and oncology, 2017-07, Vol.10 (1), p.133-133, Article 133

2017

Volltextzugriff (PDF)

Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging

Oncotarget, 2018-03, Vol.9 (24), p.17181-17198

2018

Volltextzugriff (PDF)

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations

International journal of molecular sciences, 2023-02, Vol.24 (4), p.3739

2023

Volltextzugriff (PDF)

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

International journal of molecular sciences, 2024-02, Vol.25 (3), p.1689

2024

Volltextzugriff (PDF)

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2124

2024

Volltextzugriff (PDF)

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?

International journal of molecular sciences, 2020-02, Vol.21 (4), p.1477

2020

Volltextzugriff (PDF)

Association between circulatory levels of adipokines and bone mineral density in postmenopausal women

Menopause (New York, N.Y.), 2016-09, Vol.23 (9), p.984

2016

Volltextzugriff (PDF)

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib

Pharmaceuticals (Basel, Switzerland), 2022-03, Vol.15 (3), p.374

2022

Volltextzugriff (PDF)

Characterization Methods for Nanoparticle-Skin Interactions: An Overview

Life (Basel, Switzerland), 2024-05, Vol.14 (5), p.599

2024

Volltextzugriff (PDF)

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

Frontiers in immunology, 2020-10, Vol.11, p.572876

2020

Volltextzugriff (PDF)

The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies

Current pharmaceutical design, 2008-07, Vol.14 (21), p.2100

2008

Volltextzugriff (PDF)

TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways

Circulation (New York, N.Y.), 2003-05, Vol.107 (17), p.2250-2256

2003

Volltextzugriff (PDF)

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

Circulation research, 2007-01, Vol.100 (1), p.61-69

2007

Volltextzugriff (PDF)

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)

Blood, 2006-05, Vol.107 (10), p.4122-4129

2006

Volltextzugriff (PDF)

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity

Frontiers in physiology, 2018-07, Vol.9, p.1000-1000

2018

Volltextzugriff (PDF)

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

Blood, 2005-05, Vol.105 (9), p.3413-3419

2005

Volltextzugriff (PDF)

Vaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations

Mediators of inflammation, 2016, Vol.2016, p.3648719-3648719

2016

Volltextzugriff (PDF)

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells

Clinics (São Paulo, Brazil), 2014-01, Vol.69 (1), p.68-74

2014

Volltextzugriff (PDF)

Clinical perspectives of TRAIL: insights into central nervous system disorders

Cellular and molecular life sciences : CMLS, 2016-05, Vol.73 (10), p.2017-2027

2016

Volltextzugriff (PDF)

Tumor necrosis factor–related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway

Blood, 2002-10, Vol.100 (7), p.2421-2429

2002

Volltextzugriff (PDF)

Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells

Journal of leukocyte biology, 2008-02, Vol.83 (2), p.434-437

2008

Volltextzugriff (PDF)

TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies

Current pharmaceutical design, 2004-01, Vol.10 (29), p.3673

2004

Volltextzugriff (PDF)

Evidence for a Proangiogenic Activity of TNF-Related Apoptosis-Inducing Ligand

Neoplasia (New York, N.Y.), 2004-07, Vol.6 (4), p.364-373

2004

Volltextzugriff (PDF)

U94 of Human Herpesvirus 6 is Expressed in Latently Infected Peripheral Blood Mononuclear Cells and Blocks Viral Gene Expression in Transformed Lymphocytes in Culture

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (23), p.13911-13916

1998

Volltextzugriff (PDF)

RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

Cancer cell, 2009-12, Vol.16 (6), p.498-509

2009

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(59)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(45)
Life Sciences & Biomedicine
(43)
Humans
(41)
Apoptosis
(15)
Biological And Medical Sciences
(15)
Hematology
(14)
Cells, Cultured
(11)
Tumor Necrosis Factor-Alpha - Pharmacology
(11)
Apoptosis - Drug Effects
(10)
Apoptosis Regulatory Proteins
(10)
Cell Biology
(10)
Inflammation
(10)
Medical Sciences
(10)
Tnf-Related Apoptosis-Inducing Ligand
(10)
Signal Transduction
(8)
Trail
(8)
Imidazoles - Pharmacology
(7)
Membrane Glycoproteins - Pharmacology
(7)
Review
(7)
Animals
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer

Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging

Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations

Retinal Alterations Predict Early Prodromal Signs of Neurodegenerative Disease

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions

Sex/Gender-Specific Imbalance in CVD: Could Physical Activity Help to Improve Clinical Outcome Targeting CVD Molecular Mechanisms in Women?

Association between circulatory levels of adipokines and bone mineral density in postmenopausal women

New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib

Characterization Methods for Nanoparticle-Skin Interactions: An Overview

The IMMENSE Study: The Interplay Between iMMune and ENdothelial Cells in Mediating Cardiovascular Risk in Systemic Lupus Erythematosus

The MDM2 inhibitor Nutlins as an innovative therapeutic tool for the treatment of haematological malignancies

TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways

Antiangiogenic Activity of the MDM2 Antagonist Nutlin-3

Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL)

Effects of Hypoxia and Bed Rest on Markers of Cardiometabolic Risk: Compensatory Changes in Circulating TRAIL and Glutathione Redox Capacity

TRAIL counteracts the proadhesive activity of inflammatory cytokines in endothelial cells by down-modulating CCL8 and CXCL10 chemokine expression and release

Vaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations

Upregulation of SOCS-1 by Nutlin-3 in acute myeloid leukemia cells but not in primary normal cells

Clinical perspectives of TRAIL: insights into central nervous system disorders

Tumor necrosis factor–related apoptosis-inducing ligand induces monocytic maturation of leukemic and normal myeloid precursors through a caspase-dependent pathway

Combined treatment of CpG-oligodeoxynucleotide with Nutlin-3 induces strong immune stimulation coupled to cytotoxicity in B-chronic lymphocytic leukemic (B-CLL) cells

TNF-related apoptosis-inducing ligand (TRAIL): a potential candidate for combined treatment of hematological malignancies

Evidence for a Proangiogenic Activity of TNF-Related Apoptosis-Inducing Ligand

U94 of Human Herpesvirus 6 is Expressed in Latently Infected Peripheral Blood Mononuclear Cells and Blocks Viral Gene Expression in Transformed Lymphocytes in Culture

RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation

Suchergebnisse filtern